Researchers across the globe face common barriers in translational research that can delay the development of new interventions for patients in need.
This seminar will focus on describing the strategies and benefits of implementing a stage-gate approach in early non clinical development and for Phase 1 clinical development.
- Clear go no-go decision points
- Higher probability of success moving from non clinical to clinical phase
- Clear and favourable exit strategies
Presenter: Dr. Niamh Kinsella
With 20 years of experience from biologics development, Dr. Niamh Kinsella provides tangible and actionable advice to optimise early drug development plans.
10:00 am Registration and coffee
10:30 am Welcome: Dr. Stephanie Krumholz, General Manager NDA Switzerland
10:40 am Presentation: Navigating the Regulatory Maze – Dr. Niamh Kinsella
11:30 am Question and answer session
11:50 am Closing remarks
12:00 pm End of seminar
13:30 – 17:00 Take the opportunity to book a one to one 30 min meeting to speak directly with our experts.
Email email@example.com to book your time now.
Date: 31st October 2019
Time: 10:00 am – 12:00 pm (with the opportunity to book 1-1 meetings afterwards)
Venue: Bio-Technopark, Auditorium, Wagistrasse 25, 8952 Schlieren
The seminar is held in collaboration with Bio-Technopark® Schlieren-Zürich and will be an open and interactive workshop with the opportunity to ask questions. Specific questions can be sent in advance to firstname.lastname@example.org
Registration: RSVP by Friday 25th October 2019 to email@example.com
Contact: Katharina Gerstl at firstname.lastname@example.org
If you are unable to attend, please advise us no later than two days before the seminar.
We look forward to seeing you there!
VP Early Stage Development